½ÃÀ庸°í¼­
»óǰÄÚµå
1272074

¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø(-2027³â)

Surgical Instrument Tracking Systems Market Forecast till 2027

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Research Future | ÆäÀÌÁö Á¤º¸: ¿µ¹® 110 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀåÀº FDAÀÇ UDI ÇÁ·Î±×·¥À» ÁؼöÇϱâ À§ÇØ Áß¿äÇÑ Àåºñ, ƯÈ÷ ¼ö¼ú±â±¸ÀÇ ÀÚµ¿ ÃßÀû¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ(Surgical Instrument Tracking Systems) ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÏ¿© ½ÃÀå ¿ªÇÐ, Áö¿ª ¹× ºÎ¹® ºÐ¼®, ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ¼­·Ð

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
    • º´¿ø ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛÀÇ ³ôÀº äÅà ºñÀ²
    • ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ±â¼úÀÇ Áøº¸
    • ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ µµÀÔ¿¡ ¼ö¹ÝÇÏ´Â ³ôÀº ºñ¿ë
  • ±âȸ
    • °³¹ßµµ»ó±¹ ½ÃÀå ÁøÃâ

Á¦5Àå ½ÃÀå ¿äÀÎ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®
    • ÀÎDz
    • ¼ÒÇÁÆ®¿þ¾î °³¹ß ÇÁ·Î¼¼½º
    • ¾Æ¿ôDz
    • ¸¶ÄÉÆÃ ¹× À¯Åë
    • ¾ÖÇÁÅͼ­ºñ½º
  • COVID-19ÀÇ ¿µÇ⠺м®
    • ¼ö¿ä¿¡ ´ëÇÑ ¿µÇâ
    • °ø±Þ¿¡ ´ëÇÑ ¿µÇâ
    • ½ÃÀå ÁøÃâ±â¾÷¿¡ ´ëÇÑ ¿µÇâ

Á¦6Àå ¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • °³¿ä
  • Çϵå¿þ¾î
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°

  • °³¿ä
  • ¹ÙÄÚµå
  • RFID

Á¦8Àå ¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • °³¿ä
  • º´¿ø
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ¹Ì±¹
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
    • ¼­À¯·´
    • µ¿À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿
    • ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • °³¿ä
  • ¼¼°èÀÇ ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀï ´ë½Ãº¸µå
  • ¼¼°è ¼ö¼ú±â±¸ ÃßÀû ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå Àü·«
  • ÁÖ¿ä ¹ßÀü°ú ¼ºÀå Àü·«
    • Àμö
    • È®Àå

Á¦11Àå ±â¾÷ °³¿ä

  • GETINGE AB
  • BECTON, DICKINSON AND COMPANY
  • FORTIVE CORPORATION
  • B. BRAUN MELSUNGEN AG
  • STERIS PLC
  • STANLEY BLACK & DECKER, INC.(STANLEY HEALTHCARE)
  • MATERIAL MANAGEMENT MICROSYSTEMS
  • KEY SURGICAL
  • HALDOR ADVANCED TECHNOLOGIES
  • TGX MEDICAL SYSTEMS

Á¦12Àå ºÎ·Ï

LSH 23.05.24

Market Overview

The surgical instrument tracking systems market is experiencing significant growth due to several factors. One of the key drivers is the growing demand for automated tracking of critical equipment, particularly surgical instruments, to comply with the Unique Device Identification (UDI) program of the U.S. Food & Drug Administration (FDA). Furthermore, these systems ensure that the appropriate tools are available for each surgical procedure, ultimately improving patient outcomes. In addition, the increasing number of surgical procedures resulting from sports injuries, accidents, and cardiac surgeries, largely due to the increased prevalence of cardiovascular diseases and other chronic disorders, is also contributing to market growth.

Manufacturers are required to track surgical instruments from production to distribution to comply with regulations. Tracking systems ensure that instrument manufacturers set up tracking systems that allow them to locate devices quickly in commercial distribution. The surgical tool tracking systems market is expected to expand due to the proposed UDI requirements of the US FDA. To comply with UDI standards, manufacturers, resource and specification developers, re-packagers, and relabelers of surgical instruments must apply direct marking at the individual instrument level. Surgical equipment classified as Class I devices were expected to adhere to these FDA regulations by September 24, 2020. However, this deadline was changed to September 24, 2022. Additionally, labelers must report data to the FDA's Unique Device Identification Database (GUDID) for each device. This database serves as a reference catalog for all devices and contributes to the revenue growth of the surgical instrument monitoring systems market.

Segment Overview

The market for surgical instrument tracking systems is categorized into three components: hardware, software, and services. In 2022, the hardware segment held the largest share in the market, contributing significantly to the market revenue. Hardware advancements, such as the use of RFID chips and barcode tags, have greatly impacted the adoption of these systems for surgical instrument management and inventory management. For example, Harvard University's Wyss Institute has developed a method for embedding RFID chips onto metal surgical equipment using a vapor deposition process and a biocompatible sealant.

The market for surgical instrument tracking systems is also segmented by system type, which includes barcode tracking and radio frequency identification. In 2022, the barcode tracking segment dominated the market, while radio frequency identification is expected to experience faster growth during the forecast period of 2022 to 2027. Barcode tracking technology is currently the most widely used tracking method, and its growth in the medical device sector is a significant factor in the high revenue share of this technology. The use of 2D barcodes, such as data matrices and QR codes, is also increasing due to their cost-effectiveness, durability, and 360° readability.

Regional Analysis

The European market for surgical instrument tracking systems holds the second position in terms of market share, mainly driven by increased investment in healthcare, rising investments in surgical instrument products, and advancements in technology. Within Europe, Germany dominates the surgical instrument tracking systems market in terms of market share, while the UK market is witnessing the fastest growth.

Major Players

Key Players in the market are Steris PLC (Ireland), Becton, Getinge AB (Sweden), Fortive Corporation (US), Dickinson and Company (US), B. Braun Melsungen AG (Germany), Stanley Black & Decker Inc. (US), and Material Management Microsystems (US).

COVID 19 Impacts

The COVID-19 pandemic has significantly impacted the global surgical instrument tracking systems market. With the outbreak of the pandemic, hospitals and healthcare providers across the world have been forced to adopt stringent safety protocols, including the implementation of effective infection control measures. This has led to an increased demand for surgical instrument tracking systems, as they play a crucial role in ensuring the safety and efficacy of surgical procedures.

One of the key factors driving the growth of the surgical instrument tracking systems market is the increasing focus on patient safety and surgical instrument management. Surgical instrument tracking systems provide real-time information on the location and status of instruments, enabling healthcare providers to ensure that they are properly sterilized and ready for use in surgical procedures. This helps to reduce the risk of surgical site infections and other adverse events, thereby improving patient safety and outcomes.

Another factor driving the growth of the market is the increasing adoption of automation and digitalization in the healthcare sector. Surgical instrument tracking systems are increasingly being integrated with electronic health record (EHR) systems, enabling healthcare providers to track the entire lifecycle of surgical instruments, from procurement to disposal. This helps to improve operational efficiency and reduce costs, while also improving patient outcomes.

However, the market growth has been hindered by the disruptions caused by the pandemic, such as supply chain disruptions and the postponement of elective surgeries. Many hospitals and healthcare providers have been forced to delay their investments in surgical instrument tracking systems due to budgetary constraints caused by the pandemic. Additionally, the high cost of these systems is a significant barrier to adoption, particularly in developing countries.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW 14
    • 1.1.1 MARKET SYNOPSIS 14

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 15
  • 2.2 RESEARCH OBJECTIVE 15
  • 2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY

    • 3.1.1 OVERVIEW 17
  • 3.2 DATA MINING 17
  • 3.3 SECONDARY RESEARCH 18
  • 3.4 PRIMARY RESEARCH 19
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20
  • 3.5 FORECASTING TECHNIQUES 20
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
    • 3.6.1 BOTTOM-UP APPROACH 22
    • 3.6.2 TOP-DOWN APPROACH 22
  • 3.7 DATA TRIANGULATION 23
  • 3.8 VALIDATION 23

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 24
  • 4.2 DRIVERS 25
    • 4.2.1 HIGH RATE OF ADOPTION OF THE SURGICAL INSTRUMENT TRACKING SYSTEMS BY HOSPITALS 25
    • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN SURGICAL INSTRUMENT TRACKING SYSTEM 25
    • 4.2.3 GROWING NUMBER OF SURGICAL PROCEDURES 25
  • 4.3 RESTRAINTS 26
    • 4.3.1 HIGH COST ASSOCIATED WITH IMPLEMENTATION OF SURGICAL INSTRUMENT TRACKING SYSTEM 26
  • 4.4 OPPORTUNITIES 27
    • 4.4.1 ENTERING DEVELOPING MARKETS 27

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL 28
    • 5.1.1 THREAT OF NEW ENTRANTS 29
    • 5.1.2 BARGAINING POWER OF SUPPLIERS 29
    • 5.1.3 THREAT OF SUBSTITUTES 29
    • 5.1.4 BARGAINING POWER OF BUYERS 29
    • 5.1.5 INTENSITY OF RIVALRY 29
  • 5.2 VALUE CHAIN ANALYSIS 30
    • 5.2.1 INPUTS 30
    • 5.2.2 SOFTWARE DEVELOPMENT PROCESSES 30
    • 5.2.3 OUTPUT 31
    • 5.2.4 MARKETING AND DISTRIBUTION 31
    • 5.2.5 POST SELLING SERVICES 31
  • 5.3 COVID-19 IMPACT ANALYSIS 31
    • 5.3.1 IMPACT ON DEMAND 31
    • 5.3.2 IMPACT ON SUPPLY 31
    • 5.3.3 IMPACT ON MARKET PLAYER 32

6 GLOBAL SURGICAL INSTRUMENT TRACKING SYSTEMS MARKET, BY COMPONENT

  • 6.1 OVERVIEW 33
  • 6.2 HARDWARE 34
  • 6.3 SOFTWARE 35
  • 6.4 SERVICES 35

7 GLOBAL SURGICAL INSTRUMENT TRACKING SYSTEMS MARKET, BY TECHNOLOGY

  • 7.1 OVERVIEW 36
  • 7.2 BARCODE 37
  • 7.3 RFID 37

8 GLOBAL SURGICAL INSTRUMENT TRACKING SYSTEMS MARKET, BY END USE

  • 8.1 OVERVIEW 38
  • 8.2 HOSPITALS 39
  • 8.3 OTHERS 39

9 GLOBAL SURGICAL INSTRUMENT TRACKING SYSTEMS MARKET, BY REGION

  • 9.1 OVERVIEW 40
  • 9.2 AMERICAS 41
    • 9.2.1 NORTH AMERICA 43
      • 9.2.1.1 US 46
      • 9.2.1.2 CANADA 47
    • 9.2.2 LATIN AMERICA 48
  • 9.3 EUROPE 50
    • 9.3.1 WESTERN EUROPE 52
      • 9.3.1.1 GERMANY 55
      • 9.3.1.2 FRANCE 56
      • 9.3.1.3 UK 58
      • 9.3.1.4 ITALY 59
      • 9.3.1.5 SPAIN 60
      • 9.3.1.6 REST OF WESTERN EUROPE 62
    • 9.3.2 EASTERN EUROPE 63
  • 9.4 ASIA-PACIFIC 65
    • 9.4.1 JAPAN 67
    • 9.4.2 CHINA 69
    • 9.4.3 INDIA 70
    • 9.4.4 AUSTRALIA 71
    • 9.4.5 SOUTH KOREA 73
    • 9.4.6 REST OF ASIA-PACIFIC 74
  • 9.5 MIDDLE EAST & AFRICA 76
    • 9.5.1 MIDDLE EAST 78
    • 9.5.2 AFRICA 80

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW 82
  • 10.2 MAJOR PLAYERS IN THE GLOBAL SURGICAL INSTRUMENT TRACKING SYSTEM MARKET 82
  • 10.3 COMPETITIVE BENCHMARKING 83
  • 10.4 COMPETITOR DASHBOARD 84
  • 10.5 MAJOR GROWTH STRATEGIES IN THE GLOBAL SURGICAL INSTRUMENT TRACKING SYSTEM MARKET 85
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 85
    • 10.6.1 ACQUISITION 85
    • 10.6.2 EXPANSION 85

11 COMPANY PROFILES

  • 11.1 GETINGE AB 86
    • 11.1.1 COMPANY OVERVIEW 86
    • 11.1.2 FINANCIAL OVERVIEW 87
    • 11.1.3 PRODUCTS/SERVICES OFFERED 87
    • 11.1.4 KEY DEVELOPMENTS 88
    • 11.1.5 SWOT ANALYSIS 88
    • 11.1.6 KEY STRATEGIES 88
  • 11.2 BECTON, DICKINSON AND COMPANY 89
    • 11.2.1 COMPANY OVERVIEW 89
    • 11.2.2 FINANCIAL OVERVIEW 89
    • 11.2.3 PRODUCTS/SERVICES OFFERED 90
    • 11.2.4 KEY DEVELOPMENTS 90
    • 11.2.5 SWOT ANALYSIS 90
    • 11.2.6 KEY STRATEGIES 90
  • 11.3 FORTIVE CORPORATION 91
    • 11.3.1 COMPANY OVERVIEW 91
    • 11.3.2 FINANCIAL OVERVIEW 92
    • 11.3.3 PRODUCTS/SERVICES OFFERED 92
    • 11.3.4 KEY DEVELOPMENTS 93
    • 11.3.5 SWOT ANALYSIS 93
    • 11.3.6 KEY STRATEGIES 93
  • 11.4 B. BRAUN MELSUNGEN AG 94
    • 11.4.1 COMPANY OVERVIEW 94
    • 11.4.2 FINANCIAL OVERVIEW 94
    • 11.4.3 PRODUCTS/SERVICES OFFERED 95
    • 11.4.4 KEY DEVELOPMENTS 95
    • 11.4.5 SWOT ANALYSIS 95
    • 11.4.6 KEY STRATEGIES 96
  • 11.5 STERIS PLC 97
    • 11.5.1 COMPANY OVERVIEW 97
    • 11.5.2 FINANCIAL OVERVIEW 97
    • 11.5.3 PRODUCTS/SERVICES OFFERED 98
    • 11.5.4 KEY DEVELOPMENTS 98
    • 11.5.5 SWOT ANALYSIS 98
    • 11.5.6 KEY STRATEGIES 98
  • 11.6 STANLEY BLACK & DECKER, INC. (STANLEY HEALTHCARE) 99
    • 11.6.1 COMPANY OVERVIEW 99
    • 11.6.2 FINANCIAL OVERVIEW 99
    • 11.6.3 PRODUCTS/SERVICES OFFERED 100
    • 11.6.4 KEY DEVELOPMENTS 100
    • 11.6.5 SWOT ANALYSIS 100
    • 11.6.6 KEY STRATEGIES 100
  • 11.7 MATERIAL MANAGEMENT MICROSYSTEMS 101
    • 11.7.1 COMPANY OVERVIEW 101
    • 11.7.2 FINANCIAL OVERVIEW 101
    • 11.7.3 PRODUCTS/SERVICES OFFERED 101
    • 11.7.4 KEY DEVELOPMENTS 101
    • 11.7.5 SWOT ANALYSIS 102
    • 11.7.6 KEY STRATEGIES 102
  • 11.8 KEY SURGICAL 103
    • 11.8.1 COMPANY OVERVIEW 103
    • 11.8.2 FINANCIAL OVERVIEW 103
    • 11.8.3 PRODUCTS/SERVICES OFFERED 103
    • 11.8.4 KEY DEVELOPMENTS 103
    • 11.8.5 SWOT ANALYSIS 104
    • 11.8.6 KEY STRATEGIES 104
  • 11.9 HALDOR ADVANCED TECHNOLOGIES 105
    • 11.9.1 COMPANY OVERVIEW 105
    • 11.9.2 FINANCIAL OVERVIEW 105
    • 11.9.3 PRODUCTS/SERVICES OFFERED 105
    • 11.9.4 KEY DEVELOPMENTS 105
    • 11.9.5 SWOT ANALYSIS 106
    • 11.9.6 KEY STRATEGIES 106
  • 11.10 TGX MEDICAL SYSTEMS 107
    • 11.10.1 COMPANY OVERVIEW 107
    • 11.10.2 FINANCIAL OVERVIEW 107
    • 11.10.3 PRODUCTS/SERVICES OFFERED 107
    • 11.10.4 KEY DEVELOPMENTS 107
    • 11.10.5 SWOT ANALYSIS 108
    • 11.10.6 KEY STRATEGIES 108

12 APPENDIX

  • 12.1 REFERENCES 109
  • 12.2 RELATED REPORTS 109
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦